G. Matullo et al., XRCC1, XRCC3, XPD gene polymorphisms, smoking and P-32-DNA adducts in a sample of healthy subjects, CARCINOGENE, 22(9), 2001, pp. 1437-1445
DNA repair genes have an important role in protecting individuals from canc
er-causing agents. Polymorphisms in several DNA repair genes have been iden
tified and individuals with non-dramatic reductions in the capacity to repa
ir DNA damage are observed in the population, but the impact of specific ge
netic variants on repair phenotype and cancer risk has not yet been clarifi
ed. In 308 healthy Italian individuals belonging to the prospective Europea
n project EPIC, we have investigated the relationship between DNA damage, a
s measured by P-32-DNA adduct levels, and three genetic polymorphisms in di
fferent repair genes: XRCC1-Arg399Gln (exon 10), XRCC3-Thr241Met (exon 7) a
nd VPD-Lys751Gln (exon 23). DNA adduct levels were measured as relative add
uct level (RAL) per 10(9) normal nucleotides by DNA P-32-post-labelling ass
ay in white blood cells from peripheral blood. Genotyping was performed by
PCR-RFLP analysis. The XRCC3-241Met variant was significantly associated wi
th higher DNA adduct levels, whereas XRCC1-399Gln and XPD-751Gln were assoc
iated with higher DNA adduct levels only in never-smokers. XRCC3-241Met hom
ozygotes had an average DNA adduct level of 11.44 +/-1.48 (+/- SE) compared
with 7.69 +/-0.88 in Thr/Met heterozygotes and 6.94 +/-1.11 in Thr/Thr hom
ozygotes (F=3.206, P=0.042). Never-smoking XRCC1-399Gln homozygotes had an
average DNA adduct level of 15.60 +/-5.42 compared with 6.16 +/-0.97 in Gln
/Arg heterozygotes and 6.78 +/-1.10 in Arg/Arg homozygotes (F=5.237, P=0.00
7). A significant odds ratio (3.81, 95% CI 1.02-14.16) to have DNA adduct l
evels above median value was observed for XPD-751Gln versus XPD-751Lys neve
r-smoking homozygotes after adjustment for several confounders. These data
show that all the analysed polymorphisms could result in deficient DNA repa
ir and suggest a need for further investigation into the possible interacti
ons between these polymorphisms, smoking and other risk factors.